TAXOTERE 80 mg/4 ml concentrate for solution for infusion

DRUG2 trials

Sponsors

Ziekenhuis Aan De Stroom, Mirati Therapeutics Inc.

Conditions

Advanced Non-Small Cell Lung CancerProstate cancer

Phase 2

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial

RecruitingCTIS2022-501551-90-00

Ziekenhuis Aan De StroomProstate cancer

Start: 2023-12-13Target: 583Updated: 2026-01-23

Phase 3

A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

Active, not recruitingCTIS2023-507263-19-00

Mirati Therapeutics Inc.Advanced Non-Small Cell Lung Cancer

Start: 2020-12-23Target: 557Updated: 2025-12-22